MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
219.20%
Quick Ratio
219.20%
Cash Ratio
107.19%
Debt to Asset Ratio
51.93%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable
    • Accumulated depreciation
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
30,381
29,980
18,303
41,946
Restricted cash
42
174
110
110
Short-term investments
0
24,929
59,541
57,150
Accounts receivable
27,778
-
-
-
Other current assets
3,926
4,546
4,908
4,229
Total current assets
62,127
59,629
82,862
103,435
Operating lease right-of-use assets
2,107
2,580
3,089
3,581
Total, at cost
14,647
14,648
14,579
14,490
Accumulated depreciation
13,313
13,058
12,712
12,455
Property and equipment, net
1,334
1,590
1,867
2,035
Other assets
759
759
715
713
Total assets
66,327
64,558
88,533
109,764
Accounts payable
6,431
7,639
3,982
4,651
Accrued liabilities
18,696
11,989
13,526
13,605
Operating lease liabilities, current
3,152
3,612
3,580
3,542
Finance lease liabilities, current
64
82
145
21
Deferred revenue, current
-
-
0
168
Total current liabilities
28,343
23,322
21,233
21,987
Operating lease liabilities, net of current portion
288
659
1,525
2,380
Finance lease liabilities, net of current portion
-
-
0
122
2023 common warrants liability
5,812
8,788
12,183
13,396
Long term liability
0
0
47
46
Total liabilities
34,443
32,769
34,988
37,931
Common stock, 0.0001 par value 115,800,000 shares authorized as of june 30, 2026 and december 31, 2025 6,236,828 and 6,178,230 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
9
9
9
9
Additional paid-in capital
698,183
696,583
695,269
693,689
Accumulated deficit
-666,745
-665,241
-642,201
-622,320
Accumulated other comprehensive income
437
438
468
455
Total stockholders' equity
31,884
31,789
53,545
71,833
Total liabilities and stockholders' equity
66,327
64,558
88,533
109,764
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$30,381K (62.80%↑ Y/Y)Accounts receivable$27,778K Other current assets$3,926K (-19.70%↓ Y/Y)Restricted cash$42K (-61.82%↓ Y/Y)Total, at cost$14,647K (2.44%↑ Y/Y)Total current assets$62,127K (-51.44%↓ Y/Y)Operating leaseright-of-use assets$2,107K (-48.09%↓ Y/Y)Property and equipment,net$1,334K (-35.34%↓ Y/Y)Other assets$759K (18.59%↑ Y/Y)Accumulated depreciation$13,313K (8.81%↑ Y/Y)Total assets$66,327K (-50.76%↓ Y/Y)Total liabilities andstockholders' equity$66,327K (-50.76%↓ Y/Y)Total liabilities$34,443K (4.88%↑ Y/Y)Total stockholders'equity$31,884K (-68.70%↓ Y/Y)Accumulated deficit-$666,745K (-12.86%↓ Y/Y)Total currentliabilities$28,343K (39.86%↑ Y/Y)2023 common warrantsliability$5,812K (-36.76%↓ Y/Y)Operating leaseliabilities, net of current...$288K (-91.04%↓ Y/Y)Additional paid-in capital$698,183K (0.86%↑ Y/Y)Accumulated othercomprehensive income$437K (4.05%↑ Y/Y)Common stock, 0.0001par value...$9K (0.00%↑ Y/Y)Accrued liabilities$18,696K (53.13%↑ Y/Y)Accounts payable$6,431K (63.35%↑ Y/Y)Operating leaseliabilities, current$3,152K (-9.99%↓ Y/Y)Finance leaseliabilities, current$64K (68.42%↑ Y/Y)

Aligos Therapeutics, Inc. (ALGS)

Aligos Therapeutics, Inc. (ALGS)